Please login to the form below

Not currently logged in
Email:
Password:

European Respiratory Society

This page shows the latest European Respiratory Society news and features for those working in and with pharma, biotech and healthcare.

AZ hopes dosing will differentiate its severe asthma therapy

AZ hopes dosing will differentiate its severe asthma therapy

The UK pharma group reported the results of two studies at the European Respiratory Society (ERS) in London, which showed the interleukin-5 (IL-5) inhibitor was able to reduce attacks

Latest news

  • Roche says Esbriet boosts survival in pulmonary fibrosis Roche says Esbriet boosts survival in pulmonary fibrosis

    Positive results due to be presented at European Respiratory Society . Data due to be reported at a medical conference next week shows Roche's Esbriet can improve survival in idiopathic pulmonary ... deal. The new data - due to be presented to doctors

  • Boehringer in breach over beer drinking, lederhosen presentation Boehringer in breach over beer drinking, lederhosen presentation

    standards. The breach comes after a pulmonologist working in Germany complained about a scientific symposium organised by Boehringer at the European Respiratory Society (ERS) Congress, held in Munich last year. ... Boehringer currently markets the

  • GSK sees COPD future in triple therapy GSK sees COPD future in triple therapy

    The performance of GSK's respiratory portfolio dragged down group revenues as a whole last year, and GSK is now banking on a series of new products launches - including LAMA/LABA ... One set back for the triple therapies came last year, however, when a

  • Questions raised about affordability of asthma antibodies Questions raised about affordability of asthma antibodies

    GlaxoSmithKline (GSK) and Teva presented positive phase III trials of their respective anti-IL-5 candidates mepolizumab and reslizumab at this week's European Respiratory Society (ERS) meeting in Munich, showing

  • Boehringer's Spiriva cleared for asthma in EU Boehringer's Spiriva cleared for asthma in EU

    Approval by the European Medicines Agency (EMA) was based on the results of a phase III trial programme - called UniTinA-asthma - that collectively showed that Spiriva reduced the risk of severe ... Boehringer has also presented new data at the European

More from news
Approximately 0 fully matching, plus 16 partially matching documents found.

Latest Intelligence

  • Follow the user – democratising medical conference design Follow the user – democratising medical conference design

    increased incrementally, the curve of the European Respiratory Society congress (22, 094 vs 33, 784) saw its 2019 demographic increased by more than 50%. ... Another look at the 2020 European Respiratory Society statistics illustrates the high value

  • Exploring the potential of eosinophils Exploring the potential of eosinophils

    This study was the first to investigate an anti-IL-5 therapy in patients with nasal polyps and the data was presented for the first time at the European Respiratory Society ... GSK has an extraordinary heritage in respiratory research to try to benefit

  • GSK forges ahead with its dynamic COPD and asthma portfolio GSK forges ahead with its dynamic COPD and asthma portfolio

    Other patient and clinical interest groups put the figure even higher, with the European Respiratory Society placing the number at 300 million, with figures rising higher in nations with poor access ... COPD was a Cinderella disease when I started in

  • The long and winding road to asthma breakthroughs The long and winding road to asthma breakthroughs

    Respiratory biologics are booming thanks to scientists who refused to be derailed by early research setbacks. ... The company’s severe eosinophilic asthma biologic Nucala (mepoluzimab), an Interleukin-5 inhibitor, has been buoyed by a real-world

  • Case Study: COPD Crowdshaped Case Study: COPD Crowdshaped

    At the European Respiratory Society (ERS) congress 2015, we convened the world’s first three-university simultaneous hackathon with over 400 participants from Massachusetts Institute of Technology (MIT), Imperial College London

More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...
Rare thoughts & outcomes - navigating pathways to better outcomes in rare
...
How to pick the perfect training program for your healthcare professionals
You know your team needs training. But not all training providers and programs are created equal. Last week, we shared the benefits of working with specialist learning and development (L&D)...